8-KEarnings & ResultsExhibits & Filings

DANAHER CORP /DE/ 8-K Report, Financial Results (Jan 13, 2021)

Filed January 13, 2021For Securities:DHR

Summary

Danaher Corporation (DHR) filed an 8-K on January 13, 2021, to announce anticipated financial performance for the fourth quarter of 2020 and the full year 2020. This disclosure was made in advance of a public webcast presentation at the J.P. Morgan Healthcare Conference. Investors should note that the press release and presentation slides furnished with this 8-K contain forward-looking statements and preliminary financial information, which are not deemed "filed" for regulatory purposes but are incorporated by reference.

Key Highlights

  • 1Danaher provided an update on its anticipated financial performance for Q4 2020 and the full year 2020.
  • 2The disclosure was made in conjunction with the J.P. Morgan Healthcare Conference.
  • 3The filing includes a press release and presentation slides detailing expected financial results.
  • 4This information is furnished under Item 2.02 of Form 8-K, meaning it's not considered officially 'filed' for Section 18 purposes.
  • 5Investors can find the detailed preliminary financial information within the attached press release and presentation slides.

Frequently Asked Questions

The primary purpose of this 8-K filing is to provide investors with advance notice and details regarding Danaher's anticipated financial performance for the fourth quarter and full year of 2020, ahead of a presentation at the J.P. Morgan Healthcare Conference.

The detailed information regarding Danaher's anticipated financial performance for Q4 2020 and full year 2020 is contained within the press release (Exhibit 99.1) and the selected presentation slides (Exhibit 99.1PRE) attached to this 8-K filing.

No, the press release and presentation slides furnished with this 8-K under Item 2.02 are not considered "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934. However, they are incorporated by reference into the filing.

Danaher is commenting on its financial performance in anticipation of its participation in the J.P. Morgan Healthcare Conference, where a public webcast presentation was scheduled for January 13, 2021.